| Item Type | Name |
|
Concept
|
Snail Family Transcription Factors
|
|
Concept
|
Protein Corona
|
|
Concept
|
Alarmins
|
|
Concept
|
Protein Domains
|
|
Concept
|
Cancer-Associated Fibroblasts
|
|
Concept
|
Cetuximab
|
|
Concept
|
Adenosine Triphosphate
|
|
Concept
|
Adenoviridae
|
|
Concept
|
Adult
|
|
Concept
|
Animals
|
|
Concept
|
Hypoxia
|
|
Concept
|
Aged
|
|
Concept
|
Aged, 80 and over
|
|
Concept
|
Antibodies, Monoclonal
|
|
Concept
|
Antimalarials
|
|
Concept
|
Antimetabolites, Antineoplastic
|
|
Concept
|
Antineoplastic Agents
|
|
Concept
|
Antioxidants
|
|
Concept
|
Calcium
|
|
Concept
|
Acetylation
|
|
Concept
|
Calcium-Binding Proteins
|
|
Concept
|
Carbocyanines
|
|
Concept
|
Adenocarcinoma
|
|
Concept
|
Carcinoma, Renal Cell
|
|
Concept
|
Body Fluids
|
|
Concept
|
Carrier Proteins
|
|
Concept
|
Benzimidazoles
|
|
Concept
|
Cell Cycle
|
|
Concept
|
Cell Differentiation
|
|
Concept
|
Cell Line
|
|
Concept
|
Cell Membrane
|
|
Concept
|
Cell Movement
|
|
Concept
|
Cell Nucleus
|
|
Concept
|
Biological Transport
|
|
Concept
|
Contrast Media
|
|
Concept
|
Deoxycytidine
|
|
Concept
|
Cisplatin
|
|
Concept
|
Clathrin
|
|
Concept
|
Europium
|
|
Concept
|
Cystathionine beta-Synthase
|
|
Concept
|
Cystathionine gamma-Lyase
|
|
Concept
|
Endocytosis
|
|
Concept
|
Endoplasmic Reticulum
|
|
Concept
|
Endothelium, Vascular
|
|
Concept
|
Feasibility Studies
|
|
Concept
|
Enzyme Activation
|
|
Concept
|
Ferric Compounds
|
|
Concept
|
Dose-Response Relationship, Drug
|
|
Concept
|
Doxorubicin
|
|
Concept
|
Epithelial Cells
|
|
Concept
|
Drug Carriers
|
|
Concept
|
Drug Compounding
|
|
Concept
|
Drug Screening Assays, Antitumor
|
|
Concept
|
Drug Synergism
|
|
Concept
|
Heterocyclic Compounds, 2-Ring
|
|
Concept
|
Hexokinase
|
|
Concept
|
Guanosine Triphosphate
|
|
Concept
|
Half-Life
|
|
Concept
|
Histones
|
|
Concept
|
Homeostasis
|
|
Concept
|
Humans
|
|
Concept
|
Hydrogen Sulfide
|
|
Concept
|
Genotype
|
|
Concept
|
Ligands
|
|
Concept
|
Light
|
|
Concept
|
Liposomes
|
|
Concept
|
Glutathione
|
|
Concept
|
Kinetics
|
|
Concept
|
Glycolysis
|
|
Concept
|
Lysophospholipids
|
|
Concept
|
Gold
|
|
Concept
|
Golgi Apparatus
|
|
Concept
|
Lysosomes
|
|
Concept
|
Inflammation
|
|
Concept
|
Nitric Oxide
|
|
Concept
|
Mutation
|
|
Concept
|
Nuclear Proteins
|
|
Concept
|
Necrosis
|
|
Concept
|
Neoplasm Invasiveness
|
|
Concept
|
Neoplasm Metastasis
|
|
Concept
|
Neoplasm Proteins
|
|
Concept
|
Neoplasm Staging
|
|
Concept
|
Neoplasm Transplantation
|
|
Concept
|
Neoplasms
|
|
Concept
|
Neoplasms, Experimental
|
|
Concept
|
Neovascularization, Pathologic
|
|
Concept
|
Platinum
|
|
Concept
|
Mice, Inbred C3H
|
|
Concept
|
Mice, Hairless
|
|
Concept
|
Mice, Nude
|
|
Concept
|
Microscopy, Fluorescence
|
|
Concept
|
Microspheres
|
|
Concept
|
Middle Aged
|
|
Concept
|
Phenotype
|
|
Concept
|
Polyethylene Glycols
|
|
Concept
|
Mitochondria
|
|
Concept
|
Models, Biological
|
|
Concept
|
Models, Molecular
|
|
Concept
|
Phosphates
|
|
Concept
|
Phosphorylation
|
|
Concept
|
Phototherapy
|
|
Concept
|
Pancreatic Neoplasms
|
|
Concept
|
Pinocytosis
|
|
Concept
|
Saccharomyces cerevisiae
|
|
Concept
|
Salts
|
|
Concept
|
Repressor Proteins
|
|
Concept
|
Research
|
|
Concept
|
Particle Size
|
|
Concept
|
Scattering, Radiation
|
|
Concept
|
Retinaldehyde
|
|
Concept
|
Peptides
|
|
Concept
|
Serum Albumin, Bovine
|
|
Concept
|
Risk Factors
|
|
Concept
|
Periodicals as Topic
|
|
Concept
|
Surface Properties
|
|
Concept
|
Thrombosis
|
|
Concept
|
Pyrazines
|
|
Concept
|
Time Factors
|
|
Concept
|
Tissue Distribution
|
|
Concept
|
Pyruvate Dehydrogenase Complex
|
|
Concept
|
Radio Waves
|
|
Concept
|
Terbium
|
|
Concept
|
Transcription Factors
|
|
Concept
|
Transcription, Genetic
|
|
Concept
|
Transfection
|
|
Concept
|
Biosensing Techniques
|
|
Concept
|
Molecular Structure
|
|
Concept
|
Signal Transduction
|
|
Concept
|
Thiazoles
|
|
Concept
|
Endosomes
|
|
Concept
|
Trans-Activators
|
|
Concept
|
Down-Regulation
|
|
Concept
|
Zebrafish
|
|
Concept
|
Blotting, Western
|
|
Concept
|
Cell Hypoxia
|
|
Concept
|
Drug Design
|
|
Concept
|
Designer Drugs
|
|
Concept
|
Reproducibility of Results
|
|
Concept
|
Models, Statistical
|
|
Concept
|
Cadherins
|
|
Concept
|
Second Messenger Systems
|
|
Concept
|
Structure-Activity Relationship
|
|
Concept
|
Proto-Oncogene Proteins c-jun
|
|
Concept
|
Apoptosis
|
|
Concept
|
Paclitaxel
|
|
Concept
|
Sulfurtransferases
|
|
Concept
|
Sunburn
|
|
Concept
|
Endometrial Neoplasms
|
|
Concept
|
Reactive Oxygen Species
|
|
Concept
|
Treatment Outcome
|
|
Concept
|
Veratrum Alkaloids
|
|
Concept
|
Vimentin
|
|
Concept
|
Immunoconjugates
|
|
Concept
|
Sepsis
|
|
Concept
|
Oxidative Stress
|
|
Concept
|
Drug Resistance, Multiple
|
|
Concept
|
Disease Progression
|
|
Concept
|
Neovascularization, Physiologic
|
|
Concept
|
Microscopy, Confocal
|
|
Concept
|
Sp1 Transcription Factor
|
|
Concept
|
Drug Resistance, Neoplasm
|
|
Concept
|
Zinc Fingers
|
|
Concept
|
Drug Delivery Systems
|
|
Concept
|
Coated Materials, Biocompatible
|
|
Concept
|
Reverse Transcriptase Polymerase Chain Reaction
|
|
Concept
|
Angiogenesis Inhibitors
|
|
Concept
|
GTP Phosphohydrolases
|
|
Concept
|
Caspases
|
|
Concept
|
Surface Plasmon Resonance
|
|
Concept
|
3' Untranslated Regions
|
|
Concept
|
rac1 GTP-Binding Protein
|
|
Concept
|
Cystadenocarcinoma, Serous
|
|
Concept
|
Mice, Knockout
|
|
Concept
|
Mitogen-Activated Protein Kinase 1
|
|
Concept
|
Endothelial Cells
|
|
Concept
|
Ubiquitin Thiolesterase
|
|
Concept
|
Prognosis
|
|
Concept
|
Receptors, G-Protein-Coupled
|
|
Concept
|
Promoter Regions, Genetic
|
|
Concept
|
Nitric Oxide Donors
|
|
Concept
|
Nanotubes
|
|
Concept
|
Protein Binding
|
|
Concept
|
Protein Conformation
|
|
Concept
|
Proteins
|
|
Concept
|
Proto-Oncogene Proteins
|
|
Concept
|
S-Nitroso-N-Acetylpenicillamine
|
|
Concept
|
Nanomedicine
|
|
Concept
|
Silicon Dioxide
|
|
Concept
|
Silver
|
|
Concept
|
Skin
|
|
Concept
|
Caveolin 1
|
|
Concept
|
Cation Transport Proteins
|
|
Concept
|
Mice
|
|
Concept
|
Rats
|
|
Concept
|
Nanoconjugates
|
|
Concept
|
Epithelial-Mesenchymal Transition
|
|
Concept
|
Histone Acetyltransferases
|
|
Concept
|
Sonication
|
|
Concept
|
Spectrophotometry, Ultraviolet
|
|
Concept
|
Hypoxia-Inducible Factor-Proline Dioxygenases
|
|
Concept
|
Triglycerides
|
|
Concept
|
Hepatic Stellate Cells
|
|
Concept
|
Tumor Cells, Cultured
|
|
Concept
|
Biomarkers, Tumor
|
|
Concept
|
Neoplastic Stem Cells
|
|
Concept
|
Ultraviolet Rays
|
|
Concept
|
Umbilical Veins
|
|
Concept
|
Pancreatic Stellate Cells
|
|
Concept
|
Folate Receptor 1
|
|
Concept
|
Molecular Targeted Therapy
|
|
Concept
|
Tumor Microenvironment
|
|
Concept
|
Gene Expression
|
|
Concept
|
Vesicular Transport Proteins
|
|
Concept
|
Dynamin II
|
|
Concept
|
RNA Interference
|
|
Concept
|
Gene Expression Regulation, Enzymologic
|
|
Concept
|
Gene Expression Regulation, Neoplastic
|
|
Concept
|
RNA, Small Interfering
|
|
Concept
|
Editorial Policies
|
|
Concept
|
Survival Rate
|
|
Concept
|
MicroRNAs
|
|
Concept
|
Biomedical Research
|
|
Concept
|
Nanotechnology
|
|
Concept
|
Intercellular Signaling Peptides and Proteins
|
|
Concept
|
Proteolysis
|
|
Concept
|
Endoplasmic Reticulum Stress
|
|
Concept
|
Carboplatin
|
|
Concept
|
Cytokines
|
|
Concept
|
Fibroblast Growth Factor 2
|
|
Concept
|
Tumor Burden
|
|
Concept
|
Casein Kinase II
|
|
Concept
|
Immunoprecipitation
|
|
Concept
|
Proto-Oncogene Proteins p21(ras)
|
|
Concept
|
Intracellular Signaling Peptides and Proteins
|
|
Concept
|
ErbB Receptors
|
|
Concept
|
Mitogen-Activated Protein Kinase 3
|
|
Concept
|
Mitogen-Activated Protein Kinase 7
|
|
Concept
|
Cell Growth Processes
|
|
Concept
|
Adaptor Proteins, Signal Transducing
|
|
Concept
|
Cell Proliferation
|
|
Concept
|
Nanostructures
|
|
Concept
|
Green Fluorescent Proteins
|
|
Concept
|
Neuropilins
|
|
Concept
|
Vascular Endothelial Growth Factor Receptor-2
|
|
Concept
|
Proteomics
|
|
Concept
|
NIH 3T3 Cells
|
|
Concept
|
Retinal Cone Photoreceptor Cells
|
|
Concept
|
Nanoparticles
|
|
Concept
|
Metal Nanoparticles
|
|
Concept
|
NADPH Oxidases
|
|
Concept
|
Vascular Endothelial Growth Factor A
|
|
Concept
|
Intracellular Space
|
|
Concept
|
Computational Biology
|
|
Concept
|
Hedgehog Proteins
|
|
Concept
|
Lipogenesis
|
|
Concept
|
Area Under Curve
|
|
Concept
|
Cytoprotection
|
|
Concept
|
Cyclin-Dependent Kinase Inhibitor p21
|
|
Concept
|
Precision Medicine
|
|
Concept
|
Gene Silencing
|
|
Concept
|
MAP Kinase Signaling System
|
|
Concept
|
Polycomb Repressive Complex 1
|
|
Concept
|
Mitochondrial Dynamics
|
|
Concept
|
Carcinoma, Pancreatic Ductal
|
|
Concept
|
Xenograft Model Antitumor Assays
|
|
Concept
|
Mitochondrial Proteins
|
|
Concept
|
Heterografts
|
|
Concept
|
Mitochondrial Membrane Transport Proteins
|
|
Concept
|
Cell Line, Tumor
|
|
Concept
|
Microarray Analysis
|
|
Concept
|
Membrane Potential, Mitochondrial
|
|
Concept
|
Microscopy, Electron, Transmission
|
|
Concept
|
Kruppel-Like Transcription Factors
|
|
Concept
|
Static Electricity
|
|
Concept
|
Sterol Regulatory Element Binding Protein 1
|
|
Concept
|
Sterol Regulatory Element Binding Protein 2
|
|
Concept
|
Hypoxia-Inducible Factor 1, alpha Subunit
|
|
Concept
|
Gene Knockdown Techniques
|
|
Concept
|
Young Adult
|
|
Concept
|
Antibodies, Immobilized
|
|
Concept
|
Histone Deacetylase 1
|
|
Concept
|
Histone Deacetylase 2
|
|
Concept
|
Immunomodulation
|
|
Concept
|
Neoplasm Grading
|
|
Concept
|
Real-Time Polymerase Chain Reaction
|
|
Concept
|
Antibodies, Monoclonal, Humanized
|
|
Concept
|
Photoacoustic Techniques
|
|
Concept
|
Human Umbilical Vein Endothelial Cells
|
|
Concept
|
Lysine Acetyltransferase 5
|
|
Concept
|
Autophagy
|
|
Concept
|
Cell Separation
|
|
Concept
|
Cell Survival
|
|
Concept
|
Cells, Cultured
|
|
Concept
|
Cholesterol
|
|
Concept
|
Diffusion
|
|
Concept
|
Disease
|
|
Concept
|
Disease Models, Animal
|
|
Concept
|
Diterpenes
|
|
Concept
|
DNA Damage
|
|
Concept
|
Docosahexaenoic Acids
|
|
Concept
|
Flow Cytometry
|
|
Concept
|
Fluorescent Dyes
|
|
Concept
|
Hyperthermia, Induced
|
|
Concept
|
Immunohistochemistry
|
|
Concept
|
Immunotherapy
|
|
Concept
|
Indocyanine Green
|
|
Concept
|
Materials Testing
|
|
Concept
|
Membrane Potentials
|
|
Concept
|
Membrane Proteins
|
|
Concept
|
Ovarian Neoplasms
|
|
Concept
|
Oxidation-Reduction
|
|
Concept
|
Oxidative Phosphorylation
|
|
Academic Article
|
On the issue of transparency and reproducibility in nanomedicine.
|
|
Academic Article
|
Publisher Correction: On the issue of transparency and reproducibility in nanomedicine.
|
|
Academic Article
|
Publisher Correction: On the issue of transparency and reproducibility in nanomedicine.
|
|
Academic Article
|
Inorganic phosphate nanorods are a novel fluorescent label in cell biology.
|
|
Academic Article
|
Intracellular gold nanoparticles enhance non-invasive radiofrequency thermal destruction of human gastrointestinal cancer cells.
|
|
Academic Article
|
Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent.
|
|
Academic Article
|
MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer.
|
|
Academic Article
|
Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer.
|
|
Academic Article
|
Gold nanoparticles: opportunities and challenges in nanomedicine.
|
|
Academic Article
|
Fabrication and functional characterization of goldnanoconjugates for potential application in ovarian cancer.
|
|
Academic Article
|
Inorganic nanoparticles in cancer therapy.
|
|
Academic Article
|
Modulating pharmacokinetics, tumor uptake and biodistribution by engineered nanoparticles.
|
|
Academic Article
|
Inhibition of tumor growth and metastasis by a self-therapeutic nanoparticle.
|
|
Academic Article
|
Probing novel roles of the mitochondrial uniporter in ovarian cancer cells using nanoparticles.
|
|
Academic Article
|
Mitochondrial BMI1 maintains bioenergetic homeostasis in cells.
|
|
Academic Article
|
Aberrant expression of JNK-associated leucine-zipper protein, JLP, promotes accelerated growth of ovarian cancer.
|
|
Academic Article
|
MICU1 drives glycolysis and chemoresistance in ovarian cancer.
|
|
Academic Article
|
LPA Induces Metabolic Reprogramming in Ovarian Cancer via a Pseudohypoxic Response.
|
|
Academic Article
|
Corrigendum: Cystathionine ß-Synthase Is Necessary for Axis Development in vivo.
|
|
Academic Article
|
Sepsis in the era of data-driven medicine: personalizing risks, diagnoses, treatments and prognoses.
|
|
Academic Article
|
Hydrogen sulfide signaling in mitochondria and disease.
|
|
Academic Article
|
Cystathionine beta synthase regulates mitochondrial dynamics and function in endothelial cells.
|
|
Academic Article
|
MicroRNA-195 controls MICU1 expression and tumor growth in ovarian cancer.
|
|
Academic Article
|
Cystathione ß-synthase regulates HIF-1a stability through persulfidation of PHD2.
|
|
Academic Article
|
Src homology 2 (SH2) domain containing protein tyrosine phosphatase-1 (SHP-1) dephosphorylates VEGF Receptor-2 and attenuates endothelial DNA synthesis, but not migration*.
|
|
Academic Article
|
Role of hedgehog signaling in ovarian cancer.
|
|
Academic Article
|
Sonochemically prepared BSA microspheres containing Gemcitabine, and their potential application in renal cancer therapeutics.
|
|
Academic Article
|
Effect of nanoparticle surface charge at the plasma membrane and beyond.
|
|
Academic Article
|
Fabrication and characterization of an inorganic gold and silica nanoparticle mediated drug delivery system for nitric oxide.
|
|
Academic Article
|
Efficient delivery of gold nanoparticles by dual receptor targeting.
|
|
Academic Article
|
Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future.
|
|
Academic Article
|
Identifying new therapeutic targets via modulation of protein corona formation by engineered nanoparticles.
|
|
Academic Article
|
Tuning pharmacokinetics and biodistribution of a targeted drug delivery system through incorporation of a passive targeting component.
|
|
Academic Article
|
Cystathionine ß-synthase regulates endothelial function via protein S-sulfhydration.
|
|
Academic Article
|
Role of cystathionine beta synthase in lipid metabolism in ovarian cancer.
|
|
Academic Article
|
MDR1 mediated chemoresistance: BMI1 and TIP60 in action.
|
|
Academic Article
|
Gold Nanoparticle Reprograms Pancreatic Tumor Microenvironment and Inhibits Tumor Growth.
|
|
Academic Article
|
BMI1, a new target of CK2a.
|
|
Academic Article
|
Cystathionine ß-synthase regulates mitochondrial morphogenesis in ovarian cancer.
|
|
Academic Article
|
Cystathionine ß-Synthase Is Necessary for Axis Development in Vivo.
|
|
Academic Article
|
Targeting Pancreatic Cancer Cells and Stellate Cells Using Designer Nanotherapeutics in vitro.
|
|
Academic Article
|
Analysing the nanoparticle-protein corona for potential molecular target identification.
|
|
Academic Article
|
Gold nanoparticles inhibit activation of cancer-associated fibroblasts by disrupting communication from tumor and microenvironmental cells.
|
|
Academic Article
|
Experimental conditions influence the formation and composition of the corona around gold nanoparticles.
|
|
Academic Article
|
Hybrid Nanosystems for Biomedical Applications.
|
|
Academic Article
|
Antiangiogenic properties of gold nanoparticles.
|
|
Academic Article
|
Regulatory role of dynamin-2 in VEGFR-2/KDR-mediated endothelial signaling.
|
|
Academic Article
|
Biological properties of "naked" metal nanoparticles.
|
|
Academic Article
|
Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis.
|
|
Academic Article
|
A core-shell nanomaterial with endogenous therapeutic and diagnostic functions.
|
|
Academic Article
|
A simple synthesis of a targeted drug delivery system with enhanced cytotoxicity.
|
|
Academic Article
|
Designing nanoconjugates to effectively target pancreatic cancer cells in vitro and in vivo.
|
|
Academic Article
|
Switching the targeting pathways of a therapeutic antibody by nanodesign.
|
|
Academic Article
|
Cystathionine beta-synthase (CBS) contributes to advanced ovarian cancer progression and drug resistance.
|
|
Academic Article
|
Sensitization of ovarian cancer cells to cisplatin by gold nanoparticles.
|
|
Academic Article
|
Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer.
|
|
Academic Article
|
Evaluating the Mechanism and Therapeutic Potential of PTC-028, a Novel Inhibitor of BMI-1 Function in Ovarian Cancer.
|
|
Academic Article
|
Inhibition of BMI1, a Therapeutic Approach in Endometrial Cancer.
|
|
Academic Article
|
Nanoparticle Interactions with the Tumor Microenvironment.
|
|
Academic Article
|
Gold Nanoparticles sensitize pancreatic cancer cells to gemcitabine.
|
|
Academic Article
|
Ubiquitin-binding associated protein 2 regulates KRAS activation and macropinocytosis in pancreatic cancer.
|
|
Academic Article
|
Targeting the TGFß pathway in uterine carcinosarcoma.
|
|
Academic Article
|
Inhibition of vascular permeability factor/vascular endothelial growth factor-mediated angiogenesis by the Kruppel-like factor KLF2.
|
|
Academic Article
|
Potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosis.
|
|
Academic Article
|
Lanthanide phosphate nanorods as inorganic fluorescent labels in cell biology research.
|
|
Academic Article
|
Protein-mediated autoreduction of gold salts to gold nanoparticles.
|
|
Academic Article
|
Noninvasive radiofrequency field-induced hyperthermic cytotoxicity in human cancer cells using cetuximab-targeted gold nanoparticles.
|
|
Academic Article
|
Mechanism of anti-angiogenic property of gold nanoparticles: role of nanoparticle size and surface charge.
|
|
Academic Article
|
Enhancing chemotherapy response with Bmi-1 silencing in ovarian cancer.
|
|
Academic Article
|
Cancer nanotechnology: emerging role of gold nanoconjugates.
|
|
Academic Article
|
Inhibiting the growth of pancreatic adenocarcinoma in vitro and in vivo through targeted treatment with designer gold nanotherapeutics.
|
|
Academic Article
|
Understanding protein-nanoparticle interaction: a new gateway to disease therapeutics.
|
|
Academic Article
|
Neuroprotectin D1 is synthesized in the cone photoreceptor cell line 661W and elicits protection against light-induced stress.
|
|
Academic Article
|
Hepatoma derived growth factor (HDGF) dynamics in ovarian cancer cells.
|
|
Academic Article
|
Inhibition of BMI1 induces autophagy-mediated necroptosis.
|
|
Academic Article
|
Probing Cellular Processes Using Engineered Nanoparticles.
|
|
Academic Article
|
Gold Nanoparticles Disrupt Tumor Microenvironment - Endothelial Cell Cross Talk To Inhibit Angiogenic Phenotypes in Vitro.
|
|
Academic Article
|
Gold Nanoparticle Transforms Activated Cancer-Associated Fibroblasts to Quiescence.
|
|
Academic Article
|
KRCC1: A potential therapeutic target in ovarian cancer.
|
|
Academic Article
|
Switching the intracellular pathway and enhancing the therapeutic efficacy of small interfering RNA by auroliposome.
|
|
Academic Article
|
When the chains do not break: the role of USP10 in physiology and pathology.
|
|
Grant
|
Development of a gold nanoparticles based targeted delivery system
|
|
Grant
|
Cystathionine beta synthase (CBS) and angiogenesis
|
|
Grant
|
Molecular Mechanism of Antiangiogenic Properties of Gold Nanoparticle
|
|
Grant
|
UBAP2, A New Molecule in Pancreatic Cancer Progression
|
|
Grant
|
Reprogramming Tumor Microenvironment by Nanoparticle
|
|
Grant
|
Normalizing aberrant metabolism in ovarian cancer by a unique drug delivery system
|
|
Academic Article
|
Improved pentamethine cyanine nanosensors for optoacoustic imaging of pancreatic cancer.
|
|
Academic Article
|
Small Non-Coding-RNA in Gynecological Malignancies.
|
|
Academic Article
|
Synergistic interventional photothermal therapy and immunotherapy using an iron oxide nanoplatform for the treatment of pancreatic cancer.
|
|
Academic Article
|
Revealing macropinocytosis using nanoparticles.
|
|
Academic Article
|
Active Targeting Significantly Outperforms Nanoparticle Size in Facilitating Tumor-Specific Uptake in Orthotopic Pancreatic Cancer.
|
|
Academic Article
|
Unraveling Autocrine Signaling Pathways through Metabolic Fingerprinting in Serous Ovarian Cancer Cells.
|
|
Academic Article
|
Patient-Derived Xenografts of High-Grade Serous Ovarian Cancer Subtype as a Powerful Tool in Pre-Clinical Research.
|
|
Academic Article
|
Evaluation of I-TAC as a potential early plasma marker to differentiate between critical and non-critical COVID-19.
|
|
Academic Article
|
Vascular Endothelial Growth Factor as an Immediate-Early Activator of Ultraviolet-Induced Skin Injury.
|